GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. Balance Sheet 2010–2020
| Dec 2020 | Dec 2019 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 5.7M | 396,000 | 254.4M | 25,000 | 54,000 | 888,000 | 147,000 | 226,000 | 129,000 | 185,000 |
| Cash & Equivalents | 5.3M | 28,000 | 576,000 | 19,000 | 47,000 | 855,000 | 43,000 | 123,000 | 92,000 | 54,000 |
| Liabilities | ||||||||||
| Total Liabilities | 35.1M | 19.7M | 2.7M | 18.9M | 50.6M | 30.5M | 6.5M | 6.6M | 5.2M | 5.7M |
| Long-Term Debt | — | — | — | — | — | — | — | — | — | — |
| Equity | ||||||||||
| Shareholders' Equity | -29.4M | -19.3M | 251.7M | -18.9M | -50.6M | -29.6M | -6.3M | -6.3M | -5.1M | -5.5M |
GT Biopharma, Inc. Balance Sheet — FAQ
GT Biopharma, Inc. (GTBP) balance sheet over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GTBP's balance sheet history?
The chart and table above show GT Biopharma, Inc.'s balance sheet by year and by quarter, including the growth rate.